CL2007003413A1 - Metodo para producir acido gamma linoleico (agl) en cartamo que comprende transformar con promotor ligado a secuencia codificante de desaturasa delta 6; metodo para producir agl en cartamo que comprende transformar con secuencias codificantes de desa - Google Patents

Metodo para producir acido gamma linoleico (agl) en cartamo que comprende transformar con promotor ligado a secuencia codificante de desaturasa delta 6; metodo para producir agl en cartamo que comprende transformar con secuencias codificantes de desa

Info

Publication number
CL2007003413A1
CL2007003413A1 CL200703413A CL2007003413A CL2007003413A1 CL 2007003413 A1 CL2007003413 A1 CL 2007003413A1 CL 200703413 A CL200703413 A CL 200703413A CL 2007003413 A CL2007003413 A CL 2007003413A CL 2007003413 A1 CL2007003413 A1 CL 2007003413A1
Authority
CL
Chile
Prior art keywords
cartamo
agl
includes transforming
linoleico
desaturasa
Prior art date
Application number
CL200703413A
Other languages
English (en)
Inventor
C Knauf Christine Shewmake Vic
Original Assignee
Arcadia Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcadia Biosciences Inc filed Critical Arcadia Biosciences Inc
Publication of CL2007003413A1 publication Critical patent/CL2007003413A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
CL200703413A 2005-05-23 2007-11-28 Metodo para producir acido gamma linoleico (agl) en cartamo que comprende transformar con promotor ligado a secuencia codificante de desaturasa delta 6; metodo para producir agl en cartamo que comprende transformar con secuencias codificantes de desa CL2007003413A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68413405P 2005-05-23 2005-05-23
US73598405P 2005-11-10 2005-11-10
PCT/US2006/020047 WO2006127789A2 (en) 2005-05-23 2006-05-22 Safflower with elevated gamma-linolenic acid

Publications (1)

Publication Number Publication Date
CL2007003413A1 true CL2007003413A1 (es) 2008-07-25

Family

ID=37452775

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703413A CL2007003413A1 (es) 2005-05-23 2007-11-28 Metodo para producir acido gamma linoleico (agl) en cartamo que comprende transformar con promotor ligado a secuencia codificante de desaturasa delta 6; metodo para producir agl en cartamo que comprende transformar con secuencias codificantes de desa

Country Status (13)

Country Link
US (2) US7893321B2 (es)
EP (1) EP1885862B1 (es)
JP (1) JP5033122B2 (es)
CN (1) CN101321872B (es)
AR (1) AR053477A1 (es)
AU (1) AU2006249983B2 (es)
BR (1) BRPI0611480B1 (es)
CA (1) CA2609367C (es)
CL (1) CL2007003413A1 (es)
ES (1) ES2550623T3 (es)
HK (1) HK1120823A1 (es)
NZ (1) NZ563676A (es)
WO (1) WO2006127789A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR052061A1 (es) * 2004-12-20 2007-02-28 Basf Plant Science Gmbh Moleculas de acido nucleico que codifican genes de desaturasa de acidos grasos de plantas y metodos de uso
JP2009543561A (ja) 2006-07-14 2009-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション イネの脂肪酸組成の改変
CA2721879A1 (en) * 2008-04-25 2009-10-29 Basf Plant Science Gmbh Plant seed oil
JP2011529689A (ja) * 2008-08-01 2011-12-15 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Δ６デサチュラーゼおよび多価不飽和脂肪酸生成におけるそれらの使用
SG11201406843WA (en) 2012-04-25 2014-11-27 Commw Scient Ind Res Org High oleic acid oils
NZ631702A (en) 2012-06-15 2017-01-27 Grains Res & Dev Corp Production of long chain polyunsaturated fatty acids in plant cells
WO2015087058A1 (en) * 2013-12-10 2015-06-18 The University Of York Desaturase nucleic acids and polypeptides
CA3241340A1 (en) 2013-12-18 2015-06-25 Grains Research And Development Corporation Lipid comprising long chain polyunsaturated fatty acids
CA2953008C (en) 2014-06-27 2024-03-19 Nuseed Pty Ltd Lipid comprising docosapentaenoic acid
SG11202107010QA (en) * 2018-12-28 2021-07-29 Nippon Suisan Kaisha Ltd DIHOMO-γ-LINOLENIC ACID-CONTAINING MICROBIAL OIL WITH REDUCED ARACHIDONIC ACID CONTENT

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4743548A (en) 1984-09-25 1988-05-10 Calgene, Inc. Plant cell microinjection technique
US5420034A (en) 1986-07-31 1995-05-30 Calgene, Inc. Seed-specific transcriptional regulation
US4943674A (en) 1987-05-26 1990-07-24 Calgene, Inc. Fruit specific transcriptional factors
US5068193A (en) 1985-11-06 1991-11-26 Calgene, Inc. Novel method and compositions for introducing alien DNA in vivo
US4795855A (en) 1985-11-14 1989-01-03 Joanne Fillatti Transformation and foreign gene expression with woody species
US5188958A (en) 1986-05-29 1993-02-23 Calgene, Inc. Transformation and foreign gene expression in brassica species
US5565347A (en) 1986-06-10 1996-10-15 Calgene, Inc. Transformation and foreign gene expression with plant species
ATE143694T1 (de) 1987-10-20 1996-10-15 Plant Genetic Systems Nv Verfahren zur herstellung eines biologisch- aktiven peptides durch expression von modifizierten speicherproteingenen in transgenetischen pflanzen
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
US5565346A (en) 1988-07-27 1996-10-15 Calgene, Inc. Transformation and regeneration system for legumes
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US5175095A (en) 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US6355861B1 (en) 1991-10-10 2002-03-12 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a Δ6-desaturase
US5614393A (en) 1991-10-10 1997-03-25 Rhone-Poulenc Agrochimie Production of γ-linolenic acid by a Δ6-desaturase
PH31293A (en) 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
US5792922A (en) 1992-04-02 1998-08-11 Sembiosys Genetics Inc. Oil-body protein cis-elements as regulatory signals
US5539092A (en) 1992-10-02 1996-07-23 Arch Development Corporation Cyanobacterial and plant acetyl-CoA carboxylase
ATE193729T1 (de) 1993-02-26 2000-06-15 Calgene Llc Geminivirus-basiertes-genexpressionsystem
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6075183A (en) 1997-04-11 2000-06-13 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US6051754A (en) 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US5972664A (en) 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
DE69830587T2 (de) * 1997-04-11 2006-05-24 Calgene Llc, Davis Verfahren und zusammensetzungen für die synthese von langkettigen, mehrfach ungesättigten fettsäuren in pflanzen.
US6432684B1 (en) 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
MX224646B (es) * 1997-04-15 2004-12-03 Commw Scient Ind Res Org Genes de acido graso epoxigenasa de vegetales y usos de los mismos
WO1999016890A2 (en) 1997-09-30 1999-04-08 The Regents Of The University Of California Production of proteins in plant seeds
US6653530B1 (en) * 1998-02-13 2003-11-25 Calgene Llc Methods for producing carotenoid compounds, tocopherol compounds, and specialty oils in plant seeds
US6492108B1 (en) 1998-03-26 2002-12-10 Incyte Genomics, Inc. Delta-6 desaturase homologs
PT1086236E (pt) * 1998-06-12 2007-12-12 Calgene Llc Ácidos gordos poliinsaturados em plantas
US6677145B2 (en) * 1998-09-02 2004-01-13 Abbott Laboratories Elongase genes and uses thereof
US6403349B1 (en) * 1998-09-02 2002-06-11 Abbott Laboratories Elongase gene and uses thereof
US6342657B1 (en) 1999-05-06 2002-01-29 Rhone-Poulenc Agro Seed specific promoters
MXPA01012605A (es) * 1999-06-07 2003-10-15 Basf Plant Science Gmbh 6-acetilenasa y 6-desaturasa de ceratodon purpureo.
US6815579B1 (en) * 1999-07-22 2004-11-09 The University Of British Columbia Plant long chain fatty acid biosynthetic enzyme
US6777591B1 (en) 1999-08-27 2004-08-17 Sembiosys Genetics Inc. Legume-like storage protein promoter isolated from flax and methods of expressing proteins in plant seeds using the promoter
CA2399349C (en) * 2000-02-09 2017-04-04 Basf Aktiengesellschaft Novel elongase gene and method for producing multiple-unsaturated fatty acids
DE10102337A1 (de) * 2001-01-19 2002-07-25 Basf Plant Science Gmbh Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren, neue Biosynthesegene sowie neue pflanzliche Expressionskonstrukte
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
MXPA03006663A (es) 2001-01-25 2004-05-31 Abbott Lab Genes de desaturasa y usos de los mismos.
BRPI0212339B1 (pt) 2001-09-05 2018-09-11 Monsanto Technology Llc método de transformação de uma planta, molécula de ácido nucleico recombinante, vetor e célula
BRPI0411479A (pt) 2003-06-17 2006-07-25 Sembiosys Genetics Inc métodos para a produção de insulina em plantas
CA3037924A1 (en) * 2003-08-01 2005-02-10 Basf Plant Science Gmbh Method for the production of polyunsaturated fatty acids in transgenic organisms

Also Published As

Publication number Publication date
CN101321872B (zh) 2012-09-05
WO2006127789A3 (en) 2007-11-29
WO2006127789A2 (en) 2006-11-30
WO2006127789A9 (en) 2012-03-01
EP1885862A4 (en) 2009-02-25
CA2609367A1 (en) 2006-11-30
AU2006249983A1 (en) 2006-11-30
BRPI0611480B1 (pt) 2016-06-07
JP2008545411A (ja) 2008-12-18
US8192964B2 (en) 2012-06-05
AR053477A1 (es) 2007-05-09
EP1885862B1 (en) 2015-07-29
AU2006249983B2 (en) 2011-03-17
CN101321872A (zh) 2008-12-10
US7893321B2 (en) 2011-02-22
CA2609367C (en) 2014-08-19
EP1885862A2 (en) 2008-02-13
US20110129428A1 (en) 2011-06-02
HK1120823A1 (en) 2009-04-09
NZ563676A (en) 2011-01-28
BRPI0611480A2 (pt) 2010-09-14
US20070067870A1 (en) 2007-03-22
JP5033122B2 (ja) 2012-09-26
ES2550623T3 (es) 2015-11-11

Similar Documents

Publication Publication Date Title
CL2007003413A1 (es) Metodo para producir acido gamma linoleico (agl) en cartamo que comprende transformar con promotor ligado a secuencia codificante de desaturasa delta 6; metodo para producir agl en cartamo que comprende transformar con secuencias codificantes de desa
EP1913778A4 (en) METHOD FOR MODELING THE CODING OF INFORMATION OF A VIDEO SIGNAL FOR COMPRESSING / DECOMPRESSING THE INFORMATION
ATE448231T1 (de) Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
MX2013015154A (es) Reduccion de latencia en codificacion y descodificacion de video.
EP2037151A4 (en) METHOD FOR PRODUCING A MECHANISM FOR CONVERTING A ROTATION MOVEMENT INTO A LINEAR MOVEMENT AND DEVICE FOR CARRYING OUT THE METHOD
CL2007002987A1 (es) Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para tratar enfermedades relacionadas con notch3.
AR074015A1 (es) Purificacion de proteinas acidas utilizando cromatografia de hidroxiapatita ceramica
BR112013020769A2 (pt) métodos e sistemas para a geração de coeficientes de filtro e configuração de filtros
BRPI0602466A (pt) método de codificação de um sinalizador ("flag") de previsão residual, método para decodificação de uma camada de aprimoramento de um sinal de vìdeo de múltiplas camadas, codificador de vìdeo, decodificador de vìdeo, decodificador para decodificação de uma camada de aprimoramento de um sinal de vìdeo de múltiplas camadas, método de codificação realizado por um codificador de vìdeo de múltiplas camadas, e codificador de vìdeo
EP1865957A4 (en) METHOD FOR TREATING RADIATION KERATOSIS
RS54254B1 (en) PROCEDURE FOR ENCODING AND DECODING IMAGES, DEVICE FOR ENCODING AND DECODING AND RESPONSIBLE COMPUTER PROGRAMS
HRP20231737T1 (hr) Uređaj za kodiranje slike, postupak kodiranja slike, uređaj za dekodiranje slike, postupak dekodiranja slike i program
EP2050195A4 (en) ENCODING / DECODING METHOD USING LOW DENSITY VERIFICATION CODE MATRIX
CL2007002989A1 (es) Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para el diagnostico de enfermedades relacionadas con notch3.
IN2014CN04607A (es)
BRPI0605833A (pt) pregabalina livre de ácido isobutilglutárico e um processo para sua preparação
TW200613257A (en) Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
WO2012011744A3 (ko) 디블록킹 필터링 방법 및 장치 및 이를 이용한 부호화 및 복호화 방법과 장치
BR112014032585A2 (pt) codificação e decodificação de sequências de vídeo compreendendo conjuntos de imagens de referência
BRPI0407296A (pt) ácidos nucléicos que codificam agentes antelmìnticos e plantas produzidas a partir deles
KR100717353B1 (ko) 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법
ES2646515T3 (es) Método de codificación de parámetro de cuantización de imagen y método de decodificación de parámetro de cuantización de imagen
AR084288A1 (es) Codificador y metodo para codificar predictivamente, decodificador y metodo para decodificar, sistema y metodo para codificar predictivamente y decodificar y señal de informacion predictivamente codificada
HK1146487A1 (en) Synthesis of sialic acid in plants